Subclassifications Of Assets, Liabilities And Equities [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166135

Concept	As at 2023-12-31	As at 2022-12-31	As at 2021-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	429,000 EUR	176,000 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	3,828 EUR	3,607 EUR	—
Investments accounted for using equity method [abstract]
Investments accounted for using equity method	3,801 EUR	3,948 EUR	—
Trade and other non-current receivables [abstract]
Trade and other non-current receivables	1,591 EUR	1,311 EUR	—
Trade and other current receivables [abstract]
Trade and other current receivables	3,565 EUR	4,127 EUR	—
Categories of non-current financial assets [abstract]
Non-current financial assets	1,000 EUR	1,000 EUR	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	30,406 EUR	33,457 EUR	50,012 EUR
Borrowings [abstract]
Non-current portion of non-current borrowings	1,510 EUR	747,000 EUR	—
Current borrowings and current portion of non-current borrowings [abstract]
Current borrowings	241,000 EUR	138,000 EUR	—
Non-current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Trade and other current payables	3,318 EUR	2,422 EUR	—
Issued capital [abstract]
Issued capital	140,000 EUR	140,000 EUR	—
Retained earnings [abstract]
Retained earnings, profit (loss) for reporting period	15,380 EUR	11,905 EUR	—
Retained earnings, excluding profit (loss) for reporting period	65,381 EUR	53,476 EUR	—
Miscellaneous equity [abstract]
Reserve of share-based payments	2,161 EUR	1,621 EUR	—
Net assets (liabilities) [abstract]
Assets	47,681 EUR	60,728 EUR	—
Liabilities	8,613 EUR	6,819 EUR	—
Net current assets (liabilities) [abstract]
Current assets	35,308 EUR	49,801 EUR	—
Current liabilities	6,759 EUR	5,772 EUR	—
Assets less current liabilities [abstract]